
Why a Big Pharma player is shutting down a Bay Area site, consolidating at another
Bristol-Myers Squibb Co. will cut 43 scientists from its ranks as it moves to shut down a facility in Redwood City and consolidate its Bay Area operations in Brisbane. The Big Pharma company (NYSE: BMY) — the maker of the cancer immunotherapies Opdivo and …